¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23
±³À°ÀÏÀÚ : 2024-03-23
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸

´ã´çÀÚ : ¼ÛÁÖ¿µ
¿¬¶ôó : 02-585-5455

À̸ÞÀÏ : ksns1987@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í ȸ¿ø 1¸¸¿ø, ºñȸ¿ø 2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:10~09:30 The first choice of osteoporosis and osteopenia: Raloxifene and Vit. D Áø¿ëÁØ (ÀÎÁ¦´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:30~09:50 Lifelong sequential treatment of osteoporosis Á¤Á¦ÈÆ (¼øõÇâ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 09:50~10:10 Romosozumab use of clinical practice in spine field ±Ç¿µ¹Î (µ¿¾Æ´ë )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:10~10:20 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 10:45~11:05 Treat-to-target strategy of osteoporosis management ÀÌÀ¯¹Ì (¿¬¼¼´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:05~11:25 Guidelines for dental treatment during osteoporis treatment ±Ç¿ë´ë (°æÈñÄ¡´ë ±¸°­¾Ç¾È¸é¿Ü°ú )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:25~11:45 BMP pathway and research for bone regeneration ÃÖÁ¦¿ë(°æºÏÀÇ´ë ¼¼Æ÷»ýÈ­Çб³½Ç )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 11:45~11:55 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:45 ÃÊ·Ï: Comparison of the difference between vertebral height restoration and global sagittal alignment after percutaneous vertebroplasty in thoracolumbar junction (unilateral vs. bilateral) ±è±¤·Ä (´ë±¸Ä«Å縯´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 13:45~14:00 ÃÊ·Ï: Radiologic fusion rates of OLIF surgery using E-coli derived BMP-2 ÀÌ»ó¿ì (°æºÏ´ë )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:00~14:15 ÃÊ·Ï: Evaluation of the association between 2nd osteoporotic compression fractures and paraspinal muscle mass volume mesasured on MRI À±Á¦ÈÖ(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:15~14:30 ÃÊ·Ï: Does ossification of the longitudinal ligament nifluence the fusion rate of posterior cervical fusion? ÀåÇöÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:30~14:45 ÃÊ·Ï: Frailty and sarcopenia: Impact on outcomes following elective degenerative lumbar spine surgery À¯µ¿¿ì(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 14:45~15:00 ÃÊ·Ï: Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture Àü¼º¹Î(¿µ³²´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:20~15:40 Screw insertional torque measurement is spine surgery: correlation with BMD and Hounsfield unit ±èÁö¿ë(Ä«Å縯´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 15:40~16:00 The combined effects of RhBMP-2 and systemic RANKL inhibitor in patients with bone density loss undergoing PLIF À¯½ÂÁØ (À»Áö´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:00~16:20 Comparison of the efficacy of romosozumab and teriparatide for the management of osteoporotic vertebral compression fracture ¹ÚÁøÈÆ (¿ï»ê´ë ¾Æ»êº´¿ø )

Åä·Ð 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:20~16:30 Discussion ()

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:30~16:50 Effectiveness of bone cement augmented pedicle screw fixation in severe osteoporotic patients ³ë¼ºÇö(¾ÆÁÖ´ë)

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 16:50~17:10 Mini-open corpectomy and reconstruction cases for fragility fracture induced kyphosis À±¼±±Ù(¿ï»ê´ë ¾Æ»êº´¿ø )

±³À°½Ã°£ 03¿ù 23ÀÏ ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:30 Treatment of super-aged spondylitis patient with osteopenia ±èµ¿È¯(°æ»ó´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑôÃß°ñ´Ù°øÁõ¿¬±¸È¸ Á¦11ȸ Á¤±âÇмú´ëȸ : 2024-03-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°¡Á¤ÀÇÇÐȸ ÀüºÏÁöȸÃá°è¿¬¼ö°­Á : 2024-03-23
´ÙÀ½±Û 2024³â Á¦1Â÷ ´ëÇÑÇÙÀÇÇÐȸ Á¤µµ°ü¸® ½ÉÆ÷Áö¾ö : 2024-03-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
525 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ µÎÅ뿬±¸È¸ ÇмúÁý´ãȸ : 2018-09-14 0 815 2018-08-22
524 ÀüºÏ ´ëÇÑÀÇ»çÇùȸ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (2Â÷) : 2018-09-14 0 1,699 2018-08-22
523 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 769 2018-08-22
522 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Practical Disaster Preparedness - from Evidence to Practice : 2018-09-13 0 885 2018-08-22
521 ÀüºÏ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (1Â÷) : 2018-09-13 0 1,117 2018-08-22
520 °æ±â °í·Á´ëÇб³ ¾È»êº´¿ø ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¦77Â÷ ¿ù·ÊÁý´ãȸ : 2018-09-13 0 995 2018-08-22
519 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-13 0 491 2018-08-22
518 ºÎ»ê ´ëÇÑ°ñ´ë»çÇÐȸ 2018³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Á¦2Â÷ Áý´ãȸ : 2018-09-12 0 712 2018-08-22
517 ±¤ÁÖ Á¶¼±´ëº´¿ø Á¦ 157Â÷ ´ëÇÑÇǺΰúÇÐȸ È£³²Áöȸ : 2018-09-12 0 800 2018-08-22
516 ÀÎõ ÀÎõ¼º¸ðº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦39Â÷ ÀÎõÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-12 0 2,738 2018-08-22
515 ÀÎõ ±æº´¿ø Çѱ¹¿©ÀÚÀÇ»çȸ ºñŸ¹ÎDÀÇ ÀÌÇØ¿Í ÀÓ»óÀû¿ë : 2018-09-12 0 1,398 2018-08-22
514 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø À̺ñÀÎÈÄ°ú Çù·Âº´ÀÇ¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-11 0 1,079 2018-08-22
513 °æ±â °í·Á´ë¾È»êº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦ 60Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-11 0 1,756 2018-08-22
512 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Æó¼¾ÅÍ °³¿øÀÇ °­Á : 2018-09-11 0 795 2018-08-22
511 ¼­¿ï ÀÎÁ¦ÀÇ´ë ¼­¿ï¹éº´¿ø Á¦262ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö °³ÃÖ : 2018-09-10 0 733 2018-08-22
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷